Impact of integrated yoga therapy on cognitive impairment and cardiac dysfunction in relation to quality of life in breast cancer patients undergoing chemotherapy: Study protocol for a two-arm randomized controlled trial

This study protocol outlines a randomized controlled trial to assess the effects of Integrated Yoga Therapy (IYT) on cognitive impairment, cardiac dysfunction, and quality of life in breast cancer patients undergoing chemotherapy. Participants in the yoga group will practice IYT, including postures, breathing exercises, and meditation, five days per week for 14-24 weeks. The trial measures cognitive performance, brain health (fMRI and biomarkers like BDNF), and heart function (HRV and echocardiography). Expected outcomes include reduced chemotherapy-induced cognitive and cardiac side effects and improved overall well-being, addressing a critical need for non-pharmacological interventions in cancer care.

Breast cancer patients undergoing chemotherapy should consider incorporating yoga into their routine under guidance. Yoga can improve memory, focus, and emotional well-being while reducing stress and cardiac risks. This trial supports yoga as a safe complementary therapy, though broader adoption will depend on outcomes and patient accessibility. Consult with healthcare providers to tailor practices to individual needs.